Stock Screener App

Gratuito - Play StoreApp Store

Installare Installare

Dow:

Nasdaq:

S&P 500:

RGEN

$175.350.90%-1.59

Repligen Corp (RGEN)

Date: O: H: L: C: Vol:

Repligen Corp Borsa (RGEN) Ultime notizie

Form 8K Repligen Corporation For: 30 October By Investing.com - Investing.com UK

Repligen Corporation (RGEN) Surges on Revenue Beat and Raised Full-Year Organic Outlook - Yahoo Finance

Repligen Corporation (RGEN) Benefits From Biotech Momentum and Strong Earnings - Yahoo Finance

Canaccord reiterates Hold on Repligen stock after Q3 beat By Investing.com - Investing.com Canada

Repligen Posts Record Q3 Revenue, Narrows 2026 Organic Growth Outlook - TradingKey

Repligen (RGEN) Reports Record Q3 Revenue, Boosts 2026 Guidance Amid Acquisition - GuruFocus

Repligen Corp (RGEN) Q3 2026 Earnings Call Highlights: Record Re - GuruFocus

Repligen Corp (RGEN) Q3 2026 Earnings Call Highlights: Record Re - GuruFocus

Repligen Corporation Q3 2026 Earnings Call Summary - Yahoo Finance

Conestoga Small Cap Composite Q3 2026 Portfolio Activity - Seeking Alpha

Repligen Q3 2026 slides: record revenue, raised guidance, margins expand - Investing.com

Earnings call transcript: Repligen tops Q3 2026 forecasts but shares slip - Investing.com

Repligen Corp Reports Q3 2026 Results: $209.3 Million Revenue, G - GuruFocus

Repligen Q3 2026 Earnings Call Transcript - Benzinga

Repligen Q3 2026 Earnings Call Transcript - Benzinga

Q3 2026 Repligen Corporation Earnings Call Transcript - GuruFocus

Repligen (NASDAQ:RGEN) exceeds Q3 2026 expectations, full-year outlook slightly exceeds expectations - Yahoo Finance

Form 8K Repligen Corporation For: 27 October By Investing.com - Investing.com Canada

Repligen Reports Q3 Revenue Growth, Raises 2026 Guidance - TradingView

Repligen earnings beat by $0.07, revenue topped estimates - Investing.com

Repligen: Q3 Earnings Snapshot - Yahoo Finance

symbol__ Stock Quote Price and Forecast - CNN

Repligen earnings in focus as bioprocessing growth accelerates - Investing.com

Repligen Corporation Bonds — Corporate Bond Rates - TradingView

Las ETF que invierten en acciones de Repligen Corporation - TradingView

Repligen Corporation (RGEN) Stock Forecasts - Yahoo Finance

Repligen Corp (RGEN) Stock Up 3.4% but GF Value Says Overvalued -- GF Score: 85/100 - GuruFocus

Repligen to Report Third Quarter 2026 Financial Results - Yahoo Finance

Form 144 REPLIGEN CORP For: 12 October By Investing.com - Investing.com Canada

RGEN5964422 Bond Profile: Coupon and Redemption - TradingView

Repligen Corp (BSP:R2GE34) Stock Holders - Institutional & Insider Ownership - GuruFocus

Is It Too Late to Buy Repligen Corp (RGEN) After 6.1% Rally? GF Value Says Undervalued - GuruFocus

Repligen Corp (RGEN) Insider Trading Activity | Apple Insider Buys and Sells - GuruFocus

Repligen Corporation (RGEN) Stock Forecasts - Yahoo Finance

A 700-share stock grant joins options with a $174.86 exercise price for Repligen (RGEN)’s chief product officer. - Stock Titan

Repligen Corp at Leerink Global Healthcare Conference Transcript - GuruFocus

One holder reports no voting power in Repligen (RGEN), despite a 7.36M-share passive stake. - Stock Titan

Repligen CEO Olivier Loeillot sells $1.03m of company stock By Investing.com - Investing.com Nigeria

Repligen Corp (RGEN) CEO Olivier Loeillot Sells 5,535 Shares - GuruFocus

Repligen Corp (RGEN) Shares Fall 7.7% -- What GF Score of 85 Tel - GuruFocus

Repligen CEO Olivier Loeillot sells $1.03m of company stock - Investing.com

Repligen (RGEN) CEO sells shares at $190 and $178.75 under a preset trading plan. - Stock Titan

Repligen Closes BioLife Solutions Acquisition - Yahoo Finance

Repligen completes acquisition of BioLife Solutions - Investing.com

18 commercially approved therapies are supported by BioLife's cell-preserving media. Repligen completed the deal. - stocktitan.net

Repligen Completes Acquisition of BioLife Solutions - Yahoo Finance

Repligen Insider Sold Shares Worth $1,036,654, According to a Recent SEC Filing - Yahoo Finance

Form 144 REPLIGEN CORP For: 5 October By Investing.com - Investing.com South Africa

Repligen Corp (RGEN) Stock Up 4.3% but GF Value Says Overvalued -- GF Score: 85/100 - GuruFocus

Loeillot proposes selling 4,202 Repligen (RGEN) shares through Fidelity. - stocktitan.net

Simile a RGEN

ALGN$154.212.88%

AVTR$15.771.74%

ATR$140.172.16%

SOLV$83.422.57%